Psoralen

New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis

...cluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of psoralen Ultra-Violet A (PUVA) treatment, should be examined for the presence of non- melanoma skin cancer prior to and during treatment with HUMIRA. In clin...

HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity

...cluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of psoralen Ultra-Violet A (PUVA) treatment, should be examined for the presence of non- melanoma skin cancer prior to and during treatment with HUMIRA. In clin...

Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years

...cluded. All patients, and in particular patients with a medical history of extensive immunosuppressant therapy or psoriasis patients with a history of psoralen Ultra-Violet A (PUVA) treatment, should be examined for the presence of non-melanoma skin cancer prior to and during treatment with HUMIRA. In clini...

Psoralen in Medical Technology

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

...lind, placebo-controlled study evaluating the use of REMICADE induction therapy in 249 people with severe plaque psoriasis who had previously received psoralen plus ultraviolet light A (PUVA) or systemic therapy for psoriasis. Trial participants were randomized to receive REMICADE 3 mg/kg, REMICADE 5 mg/kg or...